266 related articles for article (PubMed ID: 21353593)
1. 27-Hydroxycholesterol: the first identified endogenous SERM.
Umetani M; Shaul PW
Trends Endocrinol Metab; 2011 Apr; 22(4):130-5. PubMed ID: 21353593
[TBL] [Abstract][Full Text] [Related]
2. Different effects of CYP27A1 and CYP7B1 on cognitive function: Two mouse models in comparison.
Goikolea J; Latorre-Leal M; Tsagkogianni C; Pikkupeura S; Gulyas B; Cedazo-Minguez A; Loera-Valencia R; Björkhem I; Rodriguez Rodriguez P; Maioli S
J Steroid Biochem Mol Biol; 2023 Nov; 234():106387. PubMed ID: 37648096
[TBL] [Abstract][Full Text] [Related]
3. Detection of Endogenous Selective Estrogen Receptor Modulators such as 27-Hydroxycholesterol.
Nelson ER
Methods Mol Biol; 2016; 1366():431-443. PubMed ID: 26585155
[TBL] [Abstract][Full Text] [Related]
4. 27-Hydroxycholesterol, an endogenous selective estrogen receptor modulator.
He S; Nelson ER
Maturitas; 2017 Oct; 104():29-35. PubMed ID: 28923174
[TBL] [Abstract][Full Text] [Related]
5. Re-adopting classical nuclear receptors by cholesterol metabolites.
Umetani M
J Steroid Biochem Mol Biol; 2016 Mar; 157():20-6. PubMed ID: 26563834
[TBL] [Abstract][Full Text] [Related]
6. 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator.
DuSell CD; Umetani M; Shaul PW; Mangelsdorf DJ; McDonnell DP
Mol Endocrinol; 2008 Jan; 22(1):65-77. PubMed ID: 17872378
[TBL] [Abstract][Full Text] [Related]
7. 27-Hydroxycholesterol Is an Estrogen Receptor β-Selective Negative Allosteric Modifier of 17β-Estradiol Binding.
Starkey NJE; Li Y; Drenkhahn-Weinaug SK; Liu J; Lubahn DB
Endocrinology; 2018 May; 159(5):1972-1981. PubMed ID: 29579190
[TBL] [Abstract][Full Text] [Related]
8. 27-Hydroxycholesterol: a potential endogenous regulator of estrogen receptor signaling.
DuSell CD; McDonnell DP
Trends Pharmacol Sci; 2008 Oct; 29(10):510-4. PubMed ID: 18722677
[TBL] [Abstract][Full Text] [Related]
9. Role of 27-hydroxycholesterol and its metabolism in cancer progression: Human studies.
Biasi F; Leoni V; Gamba P; Sassi K; Lizard G; Poli G
Biochem Pharmacol; 2022 Feb; 196():114618. PubMed ID: 34023292
[TBL] [Abstract][Full Text] [Related]
10. The interaction between metabolism, cancer and cardiovascular disease, connected by 27-hydroxycholesterol.
Lee WR; Ishikawa T; Umetani M
Clin Lipidol; 2014; 9(6):617-624. PubMed ID: 25632306
[TBL] [Abstract][Full Text] [Related]
11. 27-hydroxycholesterol and the expression of three estrogen-sensitive proteins in MCF7 cells.
Cruz P; Epuñán MJ; Ramírez ME; Torres CG; Valladares LE; Sierralta WD
Oncol Rep; 2012 Sep; 28(3):992-8. PubMed ID: 22710948
[TBL] [Abstract][Full Text] [Related]
12. Evidence of pomegranate methanolic extract in antagonizing the endogenous SERM, 27-hydroxycholesterol.
Vini R; Juberiya AM; Sreeja S
IUBMB Life; 2016 Feb; 68(2):116-21. PubMed ID: 26756990
[TBL] [Abstract][Full Text] [Related]
13. Marked accumulation of 27-hydroxycholesterol in the brains of Alzheimer's patients with the Swedish APP 670/671 mutation.
Shafaati M; Marutle A; Pettersson H; Lövgren-Sandblom A; Olin M; Pikuleva I; Winblad B; Nordberg A; Björkhem I
J Lipid Res; 2011 May; 52(5):1004-10. PubMed ID: 21335619
[TBL] [Abstract][Full Text] [Related]
14. Circulating 27-hydroxycholesterol and breast cancer tissue expression of CYP27A1, CYP7B1, LXR-β, and ERβ: results from the EPIC-Heidelberg cohort.
Le Cornet C; Walter B; Sookthai D; Johnson TS; Kühn T; Herpel E; Kaaks R; Fortner RT
Breast Cancer Res; 2020 Feb; 22(1):23. PubMed ID: 32075687
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer and (25R)-26-hydroxycholesterol.
Javitt NB
Steroids; 2015 Dec; 104():61-4. PubMed ID: 26299212
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D supplementation decreases serum 27-hydroxycholesterol in a pilot breast cancer trial.
Going CC; Alexandrova L; Lau K; Yeh CY; Feldman D; Pitteri SJ
Breast Cancer Res Treat; 2018 Feb; 167(3):797-802. PubMed ID: 29116467
[TBL] [Abstract][Full Text] [Related]
17. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
[TBL] [Abstract][Full Text] [Related]
18. The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis.
DuSell CD; Nelson ER; Wang X; Abdo J; Mödder UI; Umetani M; Gesty-Palmer D; Javitt NB; Khosla S; McDonnell DP
Endocrinology; 2010 Aug; 151(8):3675-85. PubMed ID: 20501668
[TBL] [Abstract][Full Text] [Related]
19. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen.
Umetani M; Domoto H; Gormley AK; Yuhanna IS; Cummins CL; Javitt NB; Korach KS; Shaul PW; Mangelsdorf DJ
Nat Med; 2007 Oct; 13(10):1185-92. PubMed ID: 17873880
[TBL] [Abstract][Full Text] [Related]
20. Obesity and Cancer: 27-Hydroxycholesterol, the Missing Link.
Asghari A; Umetani M
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32650428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
